How do TPO-R agonists impact the daily lives of chronic ITP patients? Lessons from long-term studies

Share :
Sorry, this item is currently unavailable.
Published: 4 Sep 2014
Views: 2554
Rating:
Save
Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany

Prof Giagounidis presents his talk "How do TPO-R agonists impact the daily lives of chronic idiopathic thrombocytopenic purpura patients? Lessons from long-term studies" at EHA 2014.

GlaxoSmithKline fully provided for the costs of this symposium, honoraria for the Chairs & speakers and provided input into the symposium agenda/content.